No Matches Found

Loading...
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting changes in market sentiment and price dynamics. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish technical trend, accompanied by mixed signals from key indicators such as MACD, RSI, and moving averages. This article analyses these developments in the context of the company’s price performance and broader market conditions.

6 hours ago
share
Share Via
Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update

Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update

Sudarshan Pharma Industries has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the specialty chemicals sector. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a complex interplay of price movements and indicator signals that investors should carefully consider.

Dec 04 2025 08:12 AM IST
share
Share Via
Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update

Sudarshan Pharma Industries Sees Shift in Technical Momentum Amid Market Volatility

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum as recent market data reveals changes in key indicators such as MACD, RSI, and moving averages. The stock’s price movement and technical signals suggest a nuanced market assessment amid broader sector and benchmark trends.

Dec 03 2025 08:09 AM IST
share
Share Via
Sudarshan Pharma Industries Sees Shift in Technical Momentum Amid Market Volatility

Sudarshan Pharma Industries Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit

Sudarshan Pharma Industries has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the specialty chemicals sector.

Dec 01 2025 02:45 PM IST
share
Share Via
Sudarshan Pharma Industries Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit

Sudarshan Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals

Sudarshan Pharma, a microcap player in the Specialty Chemicals sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced view of its recent financial and technical performance. The stock’s assessment now incorporates a blend of stable financial trends, attractive valuation, average quality indicators, and bearish technical signals, providing investors with a comprehensive perspective on its current standing.

Dec 01 2025 10:09 AM IST
share
Share Via
Sudarshan Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals

Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses

Sudarshan Pharma Industries has encountered significant selling pressure in the latest trading session, with the stock registering a sharp decline and exhibiting a complete absence of buyers. This distress selling signals heightened investor caution as the stock breaks a four-day streak of gains and trades well below key moving averages.

Nov 28 2025 11:10 AM IST
share
Share Via
Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses

Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses

Sudarshan Pharma Industries has experienced significant selling pressure, with the stock registering a sharp decline of 4.96% today and showing no buying interest. The persistent downward trend over multiple time frames highlights distress selling signals, as the stock trades close to its 52-week low and remains below all key moving averages.

Nov 25 2025 12:20 PM IST
share
Share Via
Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses

Sudarshan Pharma Industries Ltd Faces Significant Selling Pressure with 4.97% Daily Decline and 45.91% Year-to-Date Loss.

Sudarshan Pharma Industries Ltd is experiencing significant selling pressure, with the stock declining over the past three days. It has underperformed compared to the Sensex across various time frames, including a year-to-date drop of 45.91%. The stock is trading below multiple moving averages, indicating a downward trend.

Nov 18 2025 10:30 AM IST
share
Share Via
Sudarshan Pharma Industries Ltd Faces Significant Selling Pressure with 4.97% Daily Decline and 45.91% Year-to-Date Loss.

Sudarshan Pharma Industries Ltd Faces Selling Pressure with 4.98% Daily Loss Amidst 39.60% Year-to-Date Decline

Sudarshan Pharma Industries Ltd is experiencing notable selling pressure, with consecutive losses over recent days. The stock has declined significantly over the past week and month, contrasting sharply with the Sensex's modest decline. Yearly performance shows a substantial drop, indicating ongoing challenges in the specialty chemicals sector.

Nov 11 2025 11:46 AM IST
share
Share Via
Sudarshan Pharma Industries Ltd Faces Selling Pressure with 4.98% Daily Loss Amidst 39.60% Year-to-Date Decline

Is Sudarshan Pharma overvalued or undervalued?

As of November 7, 2025, Sudarshan Pharma is considered overvalued with a PE ratio of 41.79 and an EV to EBITDA of 22.51, significantly higher than its peers, and has underperformed the Sensex with a year-to-date return of -37.08%.

Nov 09 2025 08:12 AM IST
share
Share Via

Is Sudarshan Pharma overvalued or undervalued?

As of November 7, 2025, Sudarshan Pharma is considered overvalued with a PE ratio of 41.79, significantly higher than its peers, and has underperformed with a year-to-date return of -37.08% compared to the Sensex's 6.50% gain.

Nov 08 2025 08:12 AM IST
share
Share Via

Sudarshan Pharma Industries Ltd Faces Significant Selling Pressure, Declines 4.99% Amid Seller Dominance.

Sudarshan Pharma Industries Ltd is experiencing notable selling pressure, with its stock declining after six days of gains. Despite a recent positive week, its longer-term performance shows significant losses, including a year-to-date drop of nearly 39%. The stock remains below key moving averages, indicating market challenges.

Nov 06 2025 11:11 AM IST
share
Share Via
Sudarshan Pharma Industries Ltd Faces Significant Selling Pressure, Declines 4.99% Amid Seller Dominance.

Is Sudarshan Pharma overvalued or undervalued?

As of November 4, 2025, Sudarshan Pharma is fairly valued with a PE ratio of 42.39, underperforming the market with a year-to-date return of -36.18%, and is rated lower than attractive peers like Cipla but higher than overvalued companies like Divi's Lab.

Nov 06 2025 08:11 AM IST
share
Share Via

Is Sudarshan Pharma overvalued or undervalued?

As of November 4, 2025, Sudarshan Pharma is fairly valued with a PE Ratio of 42.39, an EV to EBITDA of 22.76, and a ROE of 12.65%, underperforming the Sensex with a year-to-date return of -36.18%.

Nov 05 2025 08:10 AM IST
share
Share Via

Is Sudarshan Pharma technically bullish or bearish?

As of 31 October 2025, Sudarshan Pharma's trend is mildly bearish, supported by bearish weekly MACD and moving averages, while the KST offers slight bullish counterbalance.

Nov 03 2025 08:09 AM IST
share
Share Via

Sudarshan Pharma Shows Mixed Technical Trends Amid Market Fluctuations and Resilience

Sudarshan Pharma Industries, a microcap in specialty chemicals, has seen stock fluctuations, closing at 27.14 after a previous close of 25.85. Despite a significant annual decline, the company recently achieved a 12.8% return over the past week, indicating resilience amid challenging market conditions.

Nov 03 2025 08:05 AM IST
share
Share Via
Sudarshan Pharma Shows Mixed Technical Trends Amid Market Fluctuations and Resilience

Is Sudarshan Pharma technically bullish or bearish?

As of October 31, 2025, Sudarshan Pharma's trend is mildly bearish, supported by bearish MACD and moving averages, while conflicting signals from Bollinger Bands and KST suggest potential recovery.

Nov 02 2025 08:10 AM IST
share
Share Via

Is Sudarshan Pharma technically bullish or bearish?

As of 31 October 2025, Sudarshan Pharma's technical trend is mildly bearish, supported by bearish signals from the MACD, moving averages, and Bollinger Bands, despite some mild bullishness indicated by the KST.

Nov 01 2025 08:18 AM IST
share
Share Via

Sudarshan Pharma Industries Ltd Gains 4.99% Today, Surges 12.80% Over Past Week Amid Strong Buying Activity

Sudarshan Pharma Industries Ltd is experiencing notable buying activity, with the stock rising significantly today and over the past week. It has shown consecutive gains for four days, reflecting strong momentum. Despite recent positive performance, the stock has faced challenges in the longer term, with a year-to-date decline.

Oct 31 2025 03:26 PM IST
share
Share Via
Sudarshan Pharma Industries Ltd Gains 4.99% Today, Surges 12.80% Over Past Week Amid Strong Buying Activity

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read